Study | Year published | n | MC/SC | Patients | EN/PN | Gln adm | Daily gln dose | Length of treatment* | Treatment benefit |
---|---|---|---|---|---|---|---|---|---|
Andrews [53] | 2011 | 502 | MC | General ICU | EN+PN | iv | 10-20 g | 5 (1-10) | None |
Beale [29] | 2008 | 55 | SC | General ICU | EN | enteral | 40 g | <10 | Morbidity |
Conejero [46] | 2002 | 84 | MC | General ICU | EN | enteral | 35 g | 10 (7-25) | Morbidity |
Garrel [47] | 2003 | 41 | SC | Burns | EN | enteral | 26 g | 30 ± 17 | Mortality |
Goeters [14] | 2002 | 95 | MC | General ICU | EN+PN | iv | 0.2 g/kg | 17 ± 11 | Mortality |
Griffiths [15] | 1997 | 84 | SC | General ICU | PN | iv | 25 g | 6 (2-91) | Mortality |
Hall [48] | 2003 | 363 | SC | General ICU | EN | enteral | 11-27 g | 10 (6-16) | None |
Houdijk [30] | 1998 | 72 | SC | Trauma | EN | enteral | 27 g | 12 ± 6 | Morbidity |
Jones [49] | 1999 | 50 | SC | General ICU | EN | enteral | 18 (11-21) g | 11 (3-47) | Morbidity |
Wernerman [17] | 2011 | 284 | MC | General ICU | EN+PN | iv | 0.28 g/kg | 12 (4-47) | Mortality |
Zhou [50] | 2003 | 40 | SC | Burns | EN | enteral | 0.35 g/kg | 12 | Morbidity |